ישראל - עברית - Ministry of Health

taro international ltd, israel - dexamethasone; levofloxacin - טיפות עיניים - levofloxacin 5 mg / 1 ml; dexamethasone 1 mg / 1 ml - dexamethasone and antiinfectives

ישראל - עברית - Ministry of Health

linevitz eliezer - mabofloxacine 20 mg - tablets - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

ישראל - עברית - Ministry of Health

linevitz eliezer - mabofloxacine 80 mg - tablets - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

ישראל - עברית - Ministry of Health

linevitz eliezer - marbofloxacin 2 %w/v - solution for injection - in ruminating and pre-ruminating calves: treatment of respiratory infections caused by susceptible strains of microorganisms. in pigs: treatment of respiratory infections and treatment of metritis mastitis agalactiasyndrome caused by susceptible strains of microorganisms.

ישראל - עברית - Ministry of Health

sanofi israel ltd - sevelamer carbonate anhydrous - טבליות מצופות פילם - sevelamer carbonate anhydrous 800 mg - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

ישראל - עברית - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 30 mg - duloxetine - duloxetine - - cymbalta is indicated for the treatment of major depressive episodes. - cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain. this has been established is studies in patients with chronic low back pain and chronic pain due to osteoarthritis when other therapies have failed or are contra-indicated.

ישראל - עברית - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 60 mg - duloxetine - duloxetine - - cymbalta is indicated for the treatment of major depressive episodes. - cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain. this has been established is studies in patients with chronic low back pain and chronic pain due to osteoarthritis when other therapies have failed or are contra-indicated..

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 60 mg - duloxetine

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 30 mg - duloxetine

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.